Xiaoyu Zhang
Senior Research Scientist, Agilent Technologies
Got a Question for Xiaoyu Zhang?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 2
Webinar
Multi-Modal Connected Workflow for Cardiac Safety Assessment of Drugs Using hiPSC-Derived Cardiomyocytes Session 2
Pharmaceutical compounds need to undergo safety assessment screening. These in vitro frontline screening assays should be multi-parametric, scalable and mechanistic enabling a high degree of predictivity and specificity.
Webinar
Multi-Modal Connected Workflow for Cardiac Safety Assessment of Drugs Using hiPSC-Derived Cardiomyocytes Session 1
Pharmaceutical compounds need to undergo safety assessment screening. These in vitro frontline screening assays should be multi-parametric, scalable and mechanistic enabling a high degree of predictivity and specificity.
Advertisement
